Abstract
Aims
To investigate whether the presence of atrial fibrillation (AF) is independently associated with adverse short-term outcomes in patients diagnosed with acute heart failure (AHF) in the emergency department (ED).
Methods
We performed a secondary analysis of patients included in the EAHFE registries 4&5. Patients were divided by the presence of sinus rhythm (SR) or AF at ED arrival. The primary outcome was 30-day all-cause mortality. Secondary outcomes included the 30-day post-discharge combined endpoint of ED revisit or hospitalisation due to AHF and all-cause mortality. We recorded 54 independent variables that can affect outcomes. Cox regression was used to investigate adjusted significant associations between AF and outcomes. Analyses were repeated according to whether AF was previously known and whether AF was considered responsible for the AHF episode.
Results
We analysed 6045 ED visits (mean age 80.4 years, 55.9% women), 3644 (60.3%) with AF. The cumulative 30-day mortality was 9.4%, and the adverse combined endpoint (ACE) was 25.9% (ED revisit with and without hospitalisation were 16.5 and 8.9% and death occurred in 4.7%). No differences were found in outcomes of AHF patients with SR and AF, and among the latter group, no differences were found depending on whether AF was considered responsible for the AHF episode. Patients with previously known AF had significantly lower 30-day mortality and higher post-discharge ACE rates, although these differences disappeared after adjustment for confounders HR 0.782, 95% CI 0.590–1.037, p = 0.087; and HR 1.131, 95% CI 0.924–1.385, p = 0.234).
Conclusion
The coexistence of AF does not impact the short-term outcomes of patients diagnosed with AHF in the ED.
Similar content being viewed by others
References
Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M et al (2014) The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol 63:1123–1133
Llorens P, Escoda R, Miró O et al (2015) Characteristics and clinical course of patients with acute heart failure and the therapeutic measures applied in Spanish emergency departments: based on the EAHFE registry (Epidemiology of Acute Heart Failure in Emergency Departments). Emergencias 27:11–22
Weintraub NL, Collins SP, Pang PS, American Heart Association Council on Clinical Cardiology and Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation et al (2010) Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association. Circulation 122:1975–1996
Storrow AB, Jenkins CA, Self WH, Alexander PT, Barrett TW, Han JH et al (2014) The burden of acute heart failure on U.S. emergency departments. JACC Heart Fail 2:269–277
Brar S, McAlister FA, Youngson E, Rowe BH (2013) Do outcomes for patients with heart failure vary by emergency department volume? Circ Heart Fail 6:1147–1154 (PMID: 24014827)
Diercks DB, Fonarow GC, Kirk JD, Emermam CL, Hollander JE, Weber JE et al (2008) for the ADHERE scientific advisory committee and investigators. Risk stratification in women enrolled in the acute decompensated heart failure national registry emergency module (ADHERE-EM). Acad Emerg Med 15:151–158
Lee DS, Stitt A, Austin PC, Stukel TA, Schull MJ, Chong A et al (2012) Prediction of heart failure mortality in emergent care. A cohort study. Ann Intern Med 156:767–775
Oliva F, Sormani P, Contri R, Campana C, Carubelli V, Cirò A et al (2018) Heart rate as a prognostic marker and therapeutic target in acute and chronic heart failure. Int J Cardiol 253:97–104
Aguirre Tejedo A, Miró O (2017) Precipitating factors in acute heart failure: a review. Emergencias 29:185–193
Arrigo M, Gayat E, Parenica J, Ishihara S, Zhang J, Choi DJ et al (2017) Precipitating factors and 90-day outcome of acute heart failure: a report from the intercontinental GREAT registry. Eur J Heart Fail 19:201–208
Miró O, Rosselló X, Gil V, Martín-Sánchez FJ, Llorens P, Herrero-Puente P et al (2017) Predicting 30-day mortality for patients with acute heart failure who are in the emergency department: a cohort study. Ann Intern Med 167:698–705
Miró O, Llorens P, Escalada X, Herrero P, Jacob J, Gil V et al (2017) Prehospital emergency care of patients with acute heart failure in Spain: the SEMICA study (emergency medical response systems for patients with acute heart failure). Emergencias 29:223–230
Carbajosa V, Martín-Sánchez FJ, Llorens P, Herrero P, Jacob J, Alquézar A et al (2016) Factors associated with short stays for patients admitted with acute heart failure. Emergencias 28:366–374
Ho KKL, Anderson KM, Kannel WB, Grosssman W, Levy D (1993) Survival after the onset of congestive heart failure in Framingham heart study subjects. Circulation 88:107–115
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37:2129–2200
Anter E, Jessup M, Callans DJ (2009) Atrial fibrillation and heart failure: treatment considerations for a dual epidemic. Circulation 119:2516–2525
Khand AU, Rankin AC, Kaye GC, Cleland JGF (2000) Systematic review of the management of atrial fibrillation in patients with heart failure. Eur Heart J 21:614–632
Ahmed A, Thornton P, Perry GJ, Allman RM, Delong JF (2004) Impact of atrial fibrillation on mortality and readmission in older adults hospitalized with heart failure. Eur J Heart Fail 6:421–426
Wang TJ, Larson MG, Levy D et al (2003) Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham heart study. Circulation 107:2920–2925
Ezekowitz JA, Hernandez AF, O’Connor CM, Starling RC, Proulx G, Weiss MH et al (2012) Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow. J Am Coll Cardiol 59:1441–1448
Packer M, O’Connor C, McMurray JJV, Wittes J, Abraham WT, Anker SD et al (2017) Effect of ularitide on cardiovascular mortality in acute heart failure. N Engl J Med 376:1956–1964
Van den Berg MP, Van Gelder IC, Van Veldhuisen DJ (2002) Impact of atrial fibrillation on mortality in patients with chronic heart failure. Eur J Hear Fail J 4:571–575
McManus DD, Saczynski JS, Lessard D et al (2013) Recent trends in the incidence, treatment, and prognosis of patients with heart failure and atrial fibrillation (the worcester heart failure study). Am J Cardiol 111:1460–1465
Miyasaka Y, Barnes ME, Gersh BJ et al (2006) Incidence and mortality risk of congestive heart failure in atrial fibrillation patients: a community-based study over two decades. Eur Heart J 27:936–941
Smit MD, Moes ML, Maass AH et al (2012) The importance of whether atrial fibrillation or heart failure develops first. Eur J Heart Fail 14:1030–1040
Newton PJ, Davidson PM, Reid CM et al (2016) Acute heart failure admissions in New South Wales and the Australian Capital Territory: the NSW HF snapshot study. Med J Aust 204:113.e1–113.e8
Abualnaja S, Podder M, Hernandez AF, McMurray JJ, Starling RC, O’Connor CM et al (2015) acute heart failure and atrial fibrillation: insights from the acute study of clinical effectiveness of nesiritide in decompensated heart failure (ASCEND-HF). TrialJ Am Heart Assoc 4:e002092
Miró Ò, Aguirre A, Herrero P, Jacob J, Martín-Sánchez FJ, Llorens P. Estudio (2015) PAPRICA-2: papel del factor precipitante del episodio de insuficiencia cardiaca aguda en el pronóstico a medio plazo. Med Clin (Barc) 145:385–389
Harjola P, Harjola VP (2017) Can we do more for patients with acute heart failure before arrival at the hospital? Emergencias 29:221–222
Miró Ò, Hazlitt M, Escalada X, Llorens P, Gil V, Martín-Sánchez FJ et al (2018) Effects of the intensity of prehospital treatment on short-term outcomes in patients with acute heart failure: the SEMICA-2 study. Clin Res Cardiol 107:347–361
Acknowledgements
This study was partially supported by grants from the Instituto de Salud Carlos III supported with funds from the Spanish Ministry of Health and FEDER (PI15/01019 and PI15/00773) and Fundació La Marató de TV3 (2015/2510). The “Emergencies: Processes and Pathologies” research group of the IDIBAPS receives financial support from the Catalonian Government for Consolidated Groups of Investigation (GRC 2009/1385 and 2014/0313).
Investigators of the ICA-SEMES (Research group on Acute Heart Failure of the Spanish Society of Emergency Medicine): Componentes del grupo ICA-SEMES: Marta Fuentes, Cristina Gil (Hospital Universitario de Salamanca), Héctor Alonso, Pablo Garmila (Hospital Marqués de Valdecilla de Santander), F. Javier Martín-Sánchez, Guillermo Llopis García, María Cecilia Yáñez-Palma, Sergio Iglesias López (Hospital Clínico San Carlos de Madrid), Òscar Miró, Víctor Gil, Rosa Escoda, Carolina Xipell, Carolina Sánchez, Josep María Gaytan (Hospital Clínic de Barcelona), María José Pérez-Durá, Eva Salvo (Hospital Politénic La Fe de Valencia), José Pavón (Hospital Dr. Negrín de Las Palmas de Gran Canaria), Antonio Noval (Hospital Insular de Las Palmas de Gran Canaria), José Manuel Torres (Hospital Reina Sofía de Córdoba), María Luisa López-Grima, Amparo Valero, Marian Ángeles Juan (Hospital Dr. Peset de Valencia), Alfons Aguirre, Maria Angels Pedragosa, Silvia Mínguez Masó (Hospital del Mar de Barcelona), María Isabel Alonso, Francisco Ruiz (Hospital de Valme de Sevilla), José Miguel Franco (Hospital Miguel Servet de Zaragoza), Ana Belén Mecina (Hospital de Alcorcón de Madrid), Josep Tost (Consorci Sanitari de Terrassa), Susana Sánchez, Virginia Carbajosa (Hospital Rio Ortega de Valladolid), Pascual Piñera, José Andrés Sánchez Nicolás (Hospital Reina Sofía de Murcia), Raquel Torres Garate (Hospital Severo Ochoa de Madrid), Aitor Alquezar, Miguel Alberto Rizzi, Sergio Herrera (Hospital de la Santa Creu i Sant Pau de Barcelona), Javier Jacob, Alex Roset, Irene Cabello (Hospital Universitari de Bellvitge de Barcelona), Fernando Richard, José María Álvarez Pérez, María Pilar López Diez. (Hospital Universitario de Burgos), Pablo Herrero-Puente, Joaquín Vázquez Álvarez, Belén Prieto García, María García García, Marta Sánchez González (Hospital Universitario Central de Asturias de Oviedo), Pere Llorens, Patricia Javaloyes, Víctor Marquina, Inmaculada Jiménez, Néstor Hernández, Benjamín Brouzet, Sergio Ramos, Ana López (Hospital General de Alicante), Juan Antonio Andueza (Hospital General Universitario Gregorio Marañón de Madrid), Rodolfo Romero (Hospital Getafe de Madrid), Martín Ruíz, Roberto Calvache (Hospital de Henares de Madrid), María Teresa Lorca, Luis Calderón (Hospital del Tajo de Madrid),Beatriz Amores Arriaga, Beatriz Sierra (Hospital Clínico Lozano Blesa de Zaragoza), Enrique Martín Mojarro (Hospital Sant Pau i Santa Tecla de Tarragona), Lisette Travería Bécquer, Guillermo Burillo (Hospital Universitario de Canarias de Tenerife), Lluís Llauger García, Gerard Corominas La Salle. (Hospital Universitari de Vic de Barcelona), Carmen Agüera Urbano, Ana Belén García Soto, Elisa Delgado Padial (Hospital Costa del Sol de Marbella de Málaga), Ester Soy Ferrer (Hospital Josep Trueta de Girona). Manuel Garrido (Hospital Virgen Macarena de Sevilla), Francisco Javier Lucas. (Hospital General de Albacete), Rut Gaya (Hospital Juan XXIII de Tarragona), Carlos Bibiano, María Mir, Beatriz Rodríguez, Natalia Sánchez (Hospital Infanta Leonor de Madrid), José Luis Carballo (Complejo Hospitalario Universitario de Ourense). Esther Rodríguez-Adrada, Belén Rodríguez (Hospital Rey Juan Carlos de Mostoles de Madrid).
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Conflict of interest
The authors state that they have no conflict of interests with the present work. The ICA-SEMES Research Group has received unrestricted support from Orion Pharma and Novartis. The present study has been designed, performed, analysed and written exclusively by the authors independently of these pharmaceutical companies.
Additional information
ICA-SEMES Research Group members are listed in acknowledgements section.
Rights and permissions
About this article
Cite this article
Romero, R., Gaytán, J.M., Aguirre, A. et al. The role of atrial fibrillation in the short-term outcomes of patients with acute heart failure. Clin Res Cardiol 108, 622–633 (2019). https://doi.org/10.1007/s00392-018-1389-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-018-1389-x